Preskočite na glavni sadržaj
OpenAI

30. lipnja 2026.

Unutar Genebench-Pro

Detaljniji pregled referentnog testa, njegovih pitanja i popratnih materijala.

Studije slučaja

Ovih 10 studija slučaja prikazuju reprezentativna pitanja iz GeneBench-Pro. Svaka studija slučaja uključuje izvorni upit, skupove podataka i popratne materijale. Za pregled referentnih vrijednosti i ključnih nalaza pogledajte najavni blog.

Napomena: pretpregledi datoteka prikazuju izvatke iz cjelovitih skupova podataka.


Studija slučaja 1

Somatska onkologija: odluka o omjeru koristi i rizika liječenja tumora na temelju strukturnih varijanti

Procijenite ima li sintetski inhibitor usmjeren na TXR1 pozitivnu kliničku korisnost u tumorima u kojima je aktivacija cilja potaknuta strukturnom varijantom. TXR1, TXR1i, DLR1 i oznake alela sa zvjezdicom su sintetičke referentne oznake. 

Ciljna podskupina treba se utvrditi na temelju dokaza iz dugih očitanja, ekspresije, kvalitete tumora i farmakogenomike prije nego što se koristi i toksičnost mogu protumačiti kao odluka o liječenju.

Objavljeni upit prikazan modelu

A molecular tumor board registry contains trial-eligible advanced solid-tumor cases considered for a TXR1-directed inhibitor. Estimate, for tumors with SV-driven TXR1 target-mediated activation at time zero, the marginal effect of TXR1i versus non-TXR1 systemic therapy on week-16 clinical benefit as if all patients had an assessable week-16 visit. Also estimate the 8-week treatment-limiting toxicity/discontinuation risk under TXR1i in the same target population. Report net clinical utility = benefit risk difference (percentage points) - 0.35 * toxicity risk (percentage points), and choose therapy_class_code 1 if TXR1i has positive net utility and 0 otherwise. 

Use percentage-point units for all non-code quantities. Positive benefit means TXR1i improves week-16 clinical benefit relative to non-TXR1 systemic therapy.

These data came from a real experiment; you will be graded not just on numerical correctness but the quality of analytical reasoning you exhibit; do not attempt to take any shortcuts.

Return your final answer as exactly one JSON object.
Do not wrap the JSON in markdown.
Do not add prose before or after the JSON.
Do not omit any keys shown in the example.
Return the JSON object in your final answer:

JSON

1
{
2
"answer": {
3
"therapy_class_code": <int>,
4
"benefit_rd_pp": <float>,
5
"toxicity_dropout_risk_pp": <float>,
6
"net_clinical_utility_pp": <float>
7
},
8
"reasoning": "<description of method and QC>"
9
}

Datoteke dostavljene modelu

patient_idanalysis_setagesexsitecalendar_periodecogtumor_burdenprior_linesprior_resistancelineage_classtherapy_classassessed16benefit16tox_stop_8wktime_zero_day
MTB0001173.8MS1P220.78731ATXR1i010
MTB0002155.2MS3P112.63701ATXR1i1000
MTB0003168.8FS4P200.89121ATXR1i1110
MTB0004182.8FS2P224.10100BTXR1i1000
MTB0005165.5FS1P317.011ATXR1i1000

Registrske kovarijate, terapija, procjena u 16. tjednu, korist i rana toksičnost.


Studija slučaja 2

Funkcionalna genomika: validacija cilja CRISPR-a: transkript lncRNA ili genomski lokus?

Odredite je li prividna ovisnost o lncRNA specifična za transkript ili je uzrokovana učincima obližnjeg lokusa i susjednog gena.

Dokazi usmjereni transkriptima moraju proći kontrole lokalnih poremećaja DNA-lokusa, represije susjednih gena, zamjena vodiča, GC-toksičnosti i učinaka ploče.

Objavljeni upit prikazan modelu

You are given pooled CRISPRi screening data, guide-level local expression measurements, transcript-targeting CasRx follow-up data, and single-guide follow-up growth measurements for a nominated lncRNA program (LINC473) and a nearby coding gene (KIN1). The identifiers LINC473, KIN1, and ANKRD42 are synthetic benchmark labels; any resemblance to real human genes is coincidental.

Estimate the requested quantities.

Definitions:

  • lncrna_specific_lfc: the pooled-screen matched-control day-10 log2 growth effect expected at 100% effective knockdown of the dominant LINC473 transcript, not local DNA-locus effects.
  • neighbor_mediated_lfc: the pooled-screen matched-control day-10 log2 growth effect expected at 100% KIN1 repression in the local LINC473-locus model after accounting for concomitant LINC473 transcript knockdown.
  • advance_target: 1 if the evidence supports advancing LINC473 as a transcript-directed target, else 0.

Conventions:

  • all growth effects are log2(day10/day0) competitive-growth effects relative to matched controls;
  • more negative numbers indicate stronger loss of fitness;
  • set advance_target to 1 only if lncrna_specific_lfc <= -0.08 and neighbor_mediated_lfc > -0.25; otherwise 0.

These data came from a real experiment; you will be graded not just on numerical correctness but the quality of analytical reasoning you exhibit; do not attempt to take any shortcuts.

Return your final answer as exactly one JSON object.
Do not wrap the JSON in markdown.
Do not add prose before or after the JSON.
Do not omit any keys shown in the example.
Return the JSON object in your final answer:

JSON

1
{
2
"answer": {
3
"advance_target": <int>,
4
"lncrna_specific_lfc": <float>,
5
"neighbor_mediated_lfc": <float>
6
},
7
"reasoning": "<description of method and QC>"
8
}

Datoteke dostavljene modelu

guide_idnominal_targetchrcoordstranddist_lnc_tss_bpdist_neighbor_tss_bpguide_gc_frac
g001LINC473chr7100014+14300.624
g002LINC473chr7100035-43670.584
g003LINC473chr7100051+116560.622
g004LINC473chr7100066-59660.617
g005LINC473chr7100088+74770.715

Vodiči za koordinate, ciljeve, udaljenosti i GC značajke


Studija slučaja 3

Statistička genetika: prioritizacija proteinskih terapijskih meta u povezanom genetskom lokusu

Procijenite izravne učinke bolesti za dva obližnja proteina koristeći cis multivarijabilnu Mendelovu randomizaciju (cis-MVMR), pritom vodeći računa o ljestvici testa, orijentaciji alela, 'prokletstvu pobjednika', LD-u i rezidualnoj lokalnoj pleiotropiji.

Dva proteina dijele korelirani lokus. Analiza mora prijeći s marginalnih povezanosti na uvjetne učinke bolesti koji uzimaju u obzir LD, izražene na zajedničkoj proteinskoj skali.

Objavljeni upit prikazan modelu

You are given association summary statistics and metadata for two nearby proteins (PROTA and PROTB), a binary disease outcome, a locus correlation reference, and protein measurement records.

Goal: estimate the direct log-odds effect of each protein on the disease outcome per +1 SD increase in log10 concentration, conditional on the other protein.

Interpretation: theta_PROTA and theta_PROTB use the same log-odds per-SD scale defined in the goal.

These data came from a real experiment; you will be graded not just on numerical correctness but the quality of analytical reasoning you exhibit; do not attempt to take any shortcuts.

Return your final answer as exactly one JSON object.
Do not wrap the JSON in markdown.
Do not add prose before or after the JSON.
Do not omit any keys shown in the example.
Return the JSON object in your final answer:

JSON

1
{
2
"answer": {
3
"theta_PROTA": <float>,
4
"theta_PROTB": <float>
5
},
6
"reasoning": "<description of method and QC>"
7
}

Datoteke dostavljene modelu

snppos_bpeffect_alleleother_allelemafbetasepval
rs20000050000000AC0.422150.0064386683107068080.0032673300912034120.04876727714241972
rs20000150010126AC0.057090.0110089933375813010.0069552392087504070.11345916603941006
rs20000250020253GT0.090210.0099220147571163190.0056330230270155180.07817048492026045
rs20000350030379GT0.483990.0105692156141645730.00322914197402374450.0010638520681901973
rs20000450040506AG0.377030.0070365513782386540.00332975923212698020.034580976884336506

Sažeci povezanosti proteina u fazi probira za PROTA.


Studija slučaja 4

Klinička genomika / probir nositelja: preostali rizik nakon probira nositelja za DRX1 uz kalibraciju CNV-a i pseudogena

Procijenite učestalosti nositeljstva specifične za podrijetlo, rezidualni rizik nakon negativnog probira, učestalost nositeljstva kod partnera te rizik za zahvaćeni konceptus na temelju podataka testa probira nositeljstva.

Procjena rezidualnog rizika ovisi o određivanjima nositeljstva koja uzimaju u obzir pseudogene, sažimanju osnivačkih haplotipova, kalibraciji testa specifičnoj za podrijetlo te standardizaciji testiranih partnera natrag na potpuni popis partnera.

Objavljeni upit prikazan modelu

Using cohort_roster.tsv.gz, partner_roster.tsv.gz, calibration_controls.tsv.gz, target_metadata.tsv.gz, and assay_observations.tsv.gz, estimate residual reproductive risk for an autosomal recessive DRX1 condition. Report all quantities on the probability scale, not as percentages: carrier_frequency_afr and carrier_frequency_eur among screening-roster adults; residual_carrier_risk_afr_negative for an AFR screening-roster adult with a negative DRX1 screen; partner_carrier_frequency_full_roster for a uniformly sampled partner_roster.tsv.gz row; and couple_reproductive_risk for an affected conceptus when the index person is AFR and screen-negative and the partner is drawn from partner_roster.tsv.gz. Assume autosomal recessive inheritance with a 1/4 affected-conceptus risk conditional on both biological parents being carriers. 

These data came from a real experiment; you will be graded not just on numerical correctness but the quality of analytical reasoning you exhibit; do not attempt to take any shortcuts.

Return your final answer as exactly one JSON object.
Do not wrap the JSON in markdown.
Do not add prose before or after the JSON.
Do not omit any keys shown in the example.
Return the JSON object in your final answer:

JSON

1
{
2
"answer": {
3
"carrier_frequency_afr": <float>,
4
"carrier_frequency_eur": <float>,
5
"residual_carrier_risk_afr_negative": <float>,
6
"partner_carrier_frequency_full_roster": <float>,
7
"couple_reproductive_risk": <float>
8
},
9
"reasoning": "<description of method and QC>"
10
}

Datoteke dostavljene modelu

sample_idcollectionancestryfamily_history_tier
S_EUR_0001screeningEUR0
S_EUR_0002screeningEUR0
S_EUR_0003screeningEUR0
S_EUR_0004screeningEUR0
S_EUR_0005screeningEUR1

Odrasle osobe s popisa za probir s podacima o podrijetlu i kontekstu probira.


Studija slučaja 5

Jednostanična genomika: eQTL aktiviranih monocita nakon korekcije ambijentalne RNA

Procijenite učinak genotipa na ekspresiju aktiviranih monocita nakon uklanjanja ambijentalne RNA i tehničke kontaminacije iz podataka jednostaničnog RNA-seq-a.

Ambijentalna RNA utječe i na ekspresiju cilja i na panel markera koji se upotrebljava za određivanje stanja aktivacije, pa se korekcija mora provesti prije eQTL modela.

Objavljeni upit prikazan modelu

Estimate the per-allele log rate ratio for CXCL10 expression in the activated monocyte subpopulation from the provided single-cell RNA-seq data. 

These data came from a real experiment; you will be graded not just on numerical correctness but the quality of analytical reasoning you exhibit; do not attempt to take any shortcuts.

Return your final answer as exactly one JSON object.
Do not wrap the JSON in markdown.
Do not add prose before or after the JSON.
Do not omit any keys shown in the example.
Return the JSON object in your final answer:

JSON

1
{
2
"answer": {
3
"beta_activated": <float>
4
},
5
"reasoning": "<description of method and QC>"
6
}

Datoteke dostavljene modelu

cell_iddonortotal_umiHBBIFI6ISG15LST1CXCL10
D01_C001D011113734835
D01_C002D01110363311210
D01_C003D0111419812639
D01_C004D01125076043217
D01_C005D0110459125115

Brojevi UMI-ja po stanici za markerske gene, markere kontaminacije i ciljni gen.


Studija slučaja 6

Strukturna genetika: ugniježđena strukturna varijanta: ekspresijska potpora i klinička povezanost

Procijenite ima li ugniježđeni strukturni subhaplotip unutar anonimnog lokusa nalik inverziji kalibriranu kliničku povezanost i vjerodostojnu ekspresijsku potporu.

Ugniježđeni signal doze kopija može biti poremećen širim smjerom inverzije, stoga kalibracija doze, potpora ekspresiji i kliničko modeliranje moraju ostati odvojeni.

Objavljeni upit prikazan modelu

Analyze the released files for anonymous Locus Q. Estimate the full-cohort source-population clinical association and molecular expression support for the calibrated nested segment-B structural copy dosage, separating the nested segment-B dosage from the broader outer-orientation dosage. Report subhap_log_or as the natural-log source-population total-effect odds ratio for case status per additional calibrated segment-B copy. Report expression_log_fc as the natural-log expression fold-change per calibrated segment-B copy for the expression-supported gene. Report target_support_code as 1 if the supported gene has a positive expression_log_fc and the clinical association is protective (subhap_log_or < 0), otherwise 0. Report n_calibrated_carriers as the number of reliable breakpoint-panel samples carrying at least one segment-B copy. 

These data came from a real experiment; you will be graded not just on numerical correctness but the quality of analytical reasoning you exhibit; do not attempt to take any shortcuts.

Return your final answer as exactly one JSON object.
Do not wrap the JSON in markdown.
Do not add prose before or after the JSON.
Do not omit any keys shown in the example.
Return the JSON object in your final answer:

JSON

1
{
2
"answer": {
3
"n_calibrated_carriers": <int>,
4
"target_support_code": <int>,
5
"expression_log_fc": <float>,
6
"subhap_log_or": <float>
7
},
8
"reasoning": "<description of method and QC>"
9
}

Datoteke dostavljene modelu

sample_idcaseageage_bandsexpc1pc2pc3ancestry_groupclinic_stratumrecruitment_stream
Q00012150.4550_640-1.01514-0.21032-0.08849EURtertiaryclinic
Q00028057.3950_640-1.25987-0.124980.2344EURregionalregistar
Q00029168.465_plus00.915980.621770.01891AFRtercijarniklinika
Q00030174.0765_plus10.21125-0.59634-0.08197EASzajednicaregistar
Q00032182.8265_plus0-1.12034-0.243720.14665EURzajednicaklinika

Klinički podaci i podaci o kovarijatama za cjelokupnu kohortu.


Studija slučaja 7

Regulatorna genomika: mjerenje jakosti kromatinskih petlji nakon maskiranja strukturnih varijanti i artefakata mapiranja

Kvantificirajte fokalnu razliku u jakosti Hi-C petlje između slučaja i kontrole nakon uklanjanja artefakata niske mapabilnosti i strukturnih varijanti iz pozadine očekivanih kontakata.

Ciljna petlja definirana je na razlučivosti od 20 kb, no model očekivanih kontakata izobličen je ako se najprije ne maskiraju kontakti niske mapabilnosti i SV traka koja je prisutna samo u slučaju (case-only).

Objavljeni upit prikazan modelu

You are given Hi-C contact matrices at 20 kb and 40 kb resolution plus bin annotations. Estimate the loop enrichment at the 20 kb interaction between `bin_id = 8` and `bin_id = 17` in `bins_20kb.tsv.gz`. Report three quantities: `case_loop_strength` (mean log2(observed/expected) across case replicates), `control_loop_strength` (mean log2(observed/expected) across control replicates), and `delta_loop_strength` (case minus control).

These data came from a real experiment; you will be graded not just on numerical correctness but the quality of analytical reasoning you exhibit; do not attempt to take any shortcuts.

Return your final answer as exactly one JSON object.
Do not wrap the JSON in markdown.
Do not add prose before or after the JSON.
Do not omit any keys shown in the example.
Return the JSON object in your final answer:

JSON

1
{
2
"answer": {
3
"case_loop_strength": <float>,
4
"control_loop_strength": <float>,
5
"delta_loop_strength": <float>
6
},
7
"reasoning": "<description of method and QC>"
8
}

Datoteke dostavljene modelu

bin_idchromstartendgc_contentmappabilityre_sites
0chr84000004200000.461990338215725940.97875742147042735
1chr84200004400000.50441242085346770.89010849434983975
2chr84400004600000.432184515849381940.90568792893267123
3chr84600004800000.47331972826812180.93765298406647893
4chr84800005000000.44449560621507480.86825655179818774

Anotacije ciljne razlučivosti po razredima


Studija slučaja 8

Statistička genetika: višeroditeljsko mapiranje QTL-a s rekonstrukcijom osnivača

Mapirajte lokus kvantitativnog obilježja na kromosomu 1 u rekombinantnoj populaciji s osam osnivača rekonstruiranjem osnivačkog podrijetla prije testiranja povezanosti s fenotipom.

Vidljivi podaci o markerima su bialelni (dvoalelni), ali biološki signal je osnivačko podrijetlo. Obranjiva analiza stoga mora rekonstruirati stanje osnivača, provjeriti orijentaciju markera i odvojiti QTL od smetajućeg vrha usklađenog sa serijom.

Objavljeni upit prikazan modelu

Map the chromosome 1 QTL in an 8-founder multi-parent population. Report the position (cM) and which founder carries the high-effect allele.

Report high_founder as "F1".."F8".

These data came from a real experiment; you will be graded not just on numerical correctness but the quality of analytical reasoning you exhibit; do not attempt to take any shortcuts.

Return your final answer as exactly one JSON object.
Do not wrap the JSON in markdown.
Do not add prose before or after the JSON.
Do not omit any keys shown in the example.
Return the JSON object in your final answer:

JSON

1
{
2
"answer": {
3
"high_founder": "<string>",
4
"qtl_pos_cM": <float>
5
},
6
"reasoning": "<description of method and QC>"
7
}

Data files:

  • markers.tsv.gz: marker metadata
  • founders.tsv.gz: founder alleles at each marker
  • ril_genotypes.npz: observed RIL genotypes (biallelic)
  • phenotypes.tsv.gz: phenotype and covariates

Datoteke dostavljene modelu

marker_idchrpos_cM
m2_065259.762431265596575
m2_103294.52656615104739
m2_107298.18761427503033
m2_079272.20130244108847
m1_054149.907510212292195

Identifikatori markera, kromosomi i položaji na genetskoj karti.


Studija slučaja 9

Populacijska genetika: roditeljsko specifično podrijetlo i vrijeme nedavne genetske mješavine

Procijenite udjele podrijetla zasebno za svakog roditelja i vrijeme nedavnog populacijskog miješanja iz faziranih segmenata lokalnog podrijetla nakon ispravljanja recipročnih artefakata i inverzije oznaka specifične za kromosom.

Udjeli podrijetla i vremena impulsa mijenjaju se ako se artefakti recipročnih segmenata, lokalna inverzija oznaka na kromosomu ili nazivnici karte nepravilno obrade.

Objavljeni upit prikazan modelu

You are given phased local-ancestry tracts for one admixed individual. Estimate, for each transmitted parental haplotype, the fraction of ancestry A across the called tract span and the number of generations since a single recent admixture pulse. Label parent1 as the haplotype with the smaller ancestry-A fraction and parent2 as the haplotype with the larger ancestry-A fraction. 

These data came from a real experiment; you will be graded not just on numerical correctness but the quality of analytical reasoning you exhibit; do not attempt to take any shortcuts.

Return your final answer as exactly one JSON object.
Do not wrap the JSON in markdown.
Do not add prose before or after the JSON.
Do not omit any keys shown in the example.
Return the JSON object in your final answer:

JSON

1
{
2
"answer": {
3
"parent1_A_fraction": <float>,
4
"parent1_t": <float>,
5
"parent2_A_fraction": <float>,
6
"parent2_t": <float>
7
},
8
"reasoning": "<description of method and QC>"
9
}

Datoteke dostavljene modelu

chromhapstart_morganend_morganancposteriorlow_complexity_frac
chr1h10.030.505A0.9850.08
chr1h10.5050.535B0.620.92
chr1h10.5351.478849A0.9850.08
chr1h11.5037271.852681B0.9850.08
chr1h11.8526812.422373A0.9850.08

Fazirani segmenti lokalnog podrijetla s koordinatama, oznakama podrijetla, posteriornim vrijednostima i anotacijama kontrole kvalitete (QC).


Studija slučaja 10

Populacijska genetika: procjena selekcije iz zašumljenih vremenskih nizova drevne DNK

Zaključite koji je od dvaju haploidnih lokusa pod jačom pozitivnom selekcijom na temelju drevnih vremenskih nizova frekvencija alela, uzimajući u obzir orijentaciju alela, usmjerenu pogrešku, genetički pomak i promjenjivu veličinu populacije.

Putanje drevnih uzoraka opterećene šumom nisu izravno usporedive sve dok se oba lokusa ne izraze na istoj ljestvici izvedenog alela i dok se dostavljene vrijednosti pogreške sekvenciranja za svaki uzorak izravno ne modeliraju.

You are given allele-frequency time series data from two haploid loci sampled over multiple generations.

One locus is under stronger positive selection than the other. Estimate the selection coefficient s for the more strongly selected locus, where s > 0 means the derived allele is favored.

Assume instrument-driven sequencing error is ~1%. The seq_error column is the average of the two directional allele-miscall rates for that locus and sample.

The selected_locus value must be "A" or "B".

These data came from a real experiment; you will be graded not just on numerical correctness but the quality of analytical reasoning you exhibit; do not attempt to take any shortcuts.

Return your final answer as exactly one JSON object.
Do not wrap the JSON in markdown.
Do not add prose before or after the JSON.
Do not omit any keys shown in the example.
Return the JSON object in your final answer:

JSON

1
{
2
"answer": {
3
"selected_locus": "<string>",
4
"s": <float>
5
},
6
"reasoning": "<description of method and QC>"
7
}

Datoteke dostavljene modelu

generationalt_readstotal_readsseq_errorsample_year
636400.16-4500
1234450.16-4278
1841550.16-4056
2438700.16-3833
3036900.16-3611

Vremenski niz broja očitanja za lokus A.